SEC Form 4 · accession 0001443194-26-000006
INTEGRATED BIOPHARMA INC · INBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William H. Milmoe
Director
Period of report
Jun 24, 2026
Accepted (ET)
Jun 25, 2026 · 11:27 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001016504
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.19 | Jun 24, 2026 | A | 50,000 | A | — | Jun 24, 2036 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027.